Alessandro Parisi

Parisi (right) in [[Messina]] in 2024. Alessandro Parisi (; born 15 April 1977) is an Italian former footballer who played as a left-back. Provided by Wikipedia
Showing 1 - 19 results of 19 for search 'Parisi, Alessandro', query time: 0.09s Refine Results
Stereotactic body radiation therapy and surgery for early lung cancer “two sides of the same coin”
Multimodality Treatment in Metastatic Gastric Cancer: From Past to Next Future

A Preliminary Evaluation of the Public Risk Perception Related to the COVID-19 Health Emergency in Italy
Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis

Topical Menthol for Treatment of Chemotherapy-induced Peripheral Neuropathy
What Is Known about Theragnostic Strategies in Colorectal Cancer

Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome
Where are we with treatment options after first line in small cell lung cancer?—report of two opposite cases treated with CAPTEM regimen and possible perspectives

Single‐institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non‐small cell lung cancer patients treated with first‐line chemotherapy
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches

Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non‐small cell lung cancer patients: A “hypothesis‐generator” preliminary report
Multicentric retrospective analysis of platinum‐pemetrexed regimens as first‐line therapy in non‐squamous non‐small cell lung cancer patients: A “snapshot” from clinical practice

Looking for A Place for Dose-Dense TMZ Regimens in GBM Patients: An Experience with MGMT Exploratory Evaluation
Prognostic Factors in Merkel Cell Carcinoma: A Retrospective Single-Center Study in 90 Patients

Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: a retrospective multicenter study
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: an update from clinical practice

Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer
Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study

Corrigendum: Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study
Search Tools: Get RSS Feed — Email this Search — Save Search